Indeed, the PEA technology has been applied for analysing protein cargo of EVs from different body fluids [40] and to reveal prognostic BMs of glioma and glioblastoma cancer patients in plasma, for example syndecan‐1 (SYND‐1 also known as SDC1) [41]. Here, SDC1 is linked to glioma.